Patents by Inventor Lidia C Sambucetti

Lidia C Sambucetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210088523
    Abstract: Disclosed herein are methods of detecting circulating tumor cells by detecting one or more of pan-cytokeratin, epidermal growth factor receptor, human epidermal growth factor receptor 2, mucin 1, plastin 3, circulating cancer associated fibroblast and programmed death-ligand using fiber-optic array scanning technology and automated digital microscopy. The methods disclosed herein can also be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Application
    Filed: April 2, 2020
    Publication date: March 25, 2021
    Inventors: Xiaohe Liu, Lidia C. Sambucetti, Peter B. Madrid, Zheng Ao
  • Patent number: 7067551
    Abstract: The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties.
    Type: Grant
    Filed: November 9, 2004
    Date of Patent: June 27, 2006
    Assignee: Novartis AG
    Inventors: Stacy W Remiszewski, Kenneth W Bair, Richard W Versace, Lawrence B Perez, Michael A Green, Lidia C Sambucetti, Sushil Sharma
  • Publication number: 20040024067
    Abstract: The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties.
    Type: Application
    Filed: November 16, 2002
    Publication date: February 5, 2004
    Inventors: Stacy William Remiszewski, Walter William Bair, Richard W. Versace, Lawrence Blas Perez, Michael Alan Green, Lidia C. Sambucetti, Sushil Sharma
  • Publication number: 20030018062
    Abstract: The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties.
    Type: Application
    Filed: August 31, 2001
    Publication date: January 23, 2003
    Inventors: Stacy W. Remiszewski, Kenneth W. Bair, Richard W. Versace, Lawrence B. Perez, Michael A. Green, Lidia C. Sambucetti, Sushil Sharma